US FDA: Ultrasonic Tools Shouldn't Be Used For Uterine Surgery
Executive Summary
Draft guidance issued Nov. 10 recommends manufacturers of surgical aspiration devices add a contraindication to their product labeling stating the tools are not for use in uterine surgery. This is due to a perceived risk of spreading cancerous tissue, which also led to a similar warning on power morcellation devices in 2014.
You may also be interested in...
Ultrasonic Aspirator Guidance Requires Warning On Uterine Use
Manufacturers of 510(k)-cleared ultrasonic aspirators have 120 days to add labeling to the products that warns against use to remove uterine fibroids.
Manufacturers, Physicians Suggest Changes To Ultrasonic Aspirator Labeling Guidance
Comments to a November draft guidance from US FDA request additional clarity and an exemption from correction reporting requirements. A physician group thinks a proposed label warning goes too far.
VENUS II Paves Way For Allergan's Ulipristal NDA In Uterine Fibroids
Ulipristal meets all primary and secondary endpoints in the pivotal VENUS II study, supporting an NDA for uterine fibroids in the second half of 2017.